|
Larry Liberti RPh, MS was awarded the status of Regulatory Affairs Certified (RAC) in 1996, and in 2000 was made a Fellow of the American Medical Writers Association. For the past 28 years, he has worked in pharmaceutical and clinical R&D. He began at Wyeth in Product Development, Clinical R&D, and Medical Affairs. He then served as the Editorial Director, North American for ADIS. He was a co-founder of PIA, specializing in regulatory writing and consulting, and Astrolabe Analytica where he helped develop the Astrolabe Message Mapping System. Both organizations are now divisions of Thomson Scientific. |
Speaking Engagements
-
Preparing Clinical Study Reports, Albuquerque, NM, October 2006
- Regulatory Aspects of Advertising and Promotion. Newtown, PA April 2006
Monitoring the value of trial register information. San Francisco, CA June, 2005
The use of metrics in benchmarking medical affairs effectiveness. Philadelphia, PA April 2005
Monitoring the value of clinical trial register information. Philadelphia, PA March 2005
Implementing compliant strategies for funding and reporting research. Washington DC, October 2003 Publications
- Liberti LE, Erdelac, L, Papaj J. In search of “clinical trial register – version 2.0”. In CLINICAL TRIAL REGISTRIES: A PRACTICAL GUIDE FOR SPONSORS AND RESEARCHERS OF MEDICINAL PRODUCTS, Foote MA, ed. 2006
-
Liberti LE, Benfield DP. Designing an effective IND-enabling programme. PharmaTech 2002:1-3
-
Liberti LE. How to prepare an effective standardized medical response letter. AMWA Journal 1990;5:5-8.
Location: Fairless Hills, PA
To contact Larry, please click here and state your requirements
Back to main Experts page
|
|